Autoinjectors Market Set to Grow at 24.2% CAGR to 2023 - Global Manufacturers, Industry Size, Applications, Opportunity and Forecast

Top players covered in autoinjectors market study are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), J&J (US), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Bayer (Germany), and Haselmeier (Switzerland).

Access Growth Projection Report Sample of Autoinjectors Market spread
Across 133 Pages, Profiling 13 Companies and
Supported with 66 Tables and 36 Figures is
Now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1592468 .

Report analyzes autoinjectors market and aims at estimating size and future growth potential of this market based on various segments like therapy, type, end user, and region. Detailed insights on upcoming technologies, research and development activities, and product launches in auto injectors market. The global autoinjector market is segmented on the basis of product type, technology, usability, design, application and geography. Based on product type, the market is segmented into fillable and prefilled autoinjectors.
Executive Summary

Premium Insights
4.1 Autoinjectors Market Overview
4.2 Autoinjectors Market, By Type, 2018 vs 2023
4.3 Geographic Analysis: Autoinjectors Market, By Therapy
4.4 Autoinjectors Market, By End User, 2018 vs 2023
4.5 Geographic Snapshot: Autoinjectors Market

Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Targeted Therapies
5.2.1.2 Rising Incidence of Anaphylaxis
5.2.1.3 Increasing Number of Regulatory Approvals
5.2.1.4 Availability of Generic Versions of Autoinjectors
5.2.1.5 Favorable Reimbursements and Government Support
5.2.1.6 Technological Advancements and Design Development
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes
5.2.2.1.1 Oral Diabetic Agents and Oral Insulin
5.2.2.1.2 Epinephrine Nasal Sprays
5.2.3 Opportunities
5.2.3.1 Patent Expiry of Biologics to Drive the Demand for Biosimilars
5.2.4 Challenges
5.2.4.1 Development of Autoinjectors for Multiple Drug Viscosities
5.2.4.2 Lack of Proper Training for Using Autoinjectors

Access More Information on Autoinjectors Market Research Now with Top Trends and Company Profiles https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1592468 .

Global auto injectors market expected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during forecast period. Growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and technological advancements in auto injector devices are expected to drive growth of auto injectors market.

Auto-injectors are preferred over conventional devices as they facilitate improved drug delivery and new formulations and thus, are increasing the demand for injectable devices. Auto-injectors enhance and improve efficiency in terms of drug delivery as they are more convenient to use. The demand for auto-injectors devices is increasing as they are designed in accordance with patient acceptance and compliance. North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.

Click Here for Corporate Discount of 22% Discount on “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023” report @ https://www.reportsnreports.com/contacts/discount.aspx?name=1592468 .

The report analyzes the auto injectors market and aims at estimating the market size and future growth potential of this market based on various segments such as therapy, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies. North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.

Snehal Shete
Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

Contact:
sales@reportsandreports.com / Call +1 888 391 5441

We provide you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.
With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.